Abstract
The use of recombinant antigens and chemically synthesized peptides are the new approaches for the construction of reliable and sensrtive diagnostic assays. Moreover, in the field of virology, the use of recombinant antigens eliminates the need to handle highly hazardous material in the preparation of the assays (1,2) and allows the assembly of multiepitope polypeptides (3). The protein purification is a critical step in the preparation of recombinant antigens. It is important to point out that the biochemical characteristics of a recombinant protein, expressed in a heterologous system, are unique. Purification problems may be very different for related structural proteins expressed in the same host or for the same protein expressed in different hosts. The designing of an antigen purification procedure is strongly dependent on the immunodominant epitopes present on its surface. The antibodies recognize chemical groupings, exposed to the solvent, on the surface of an antigen An immunodominant determinant may be continuous or discontniuous. Moreover, continuous epitopes can be sequential, if they are only defined by the primary protein sequence, or conformational, if they are associated to secondary structure elements (α-helix, β-sheet, loops). Discontinuous epitopes are, instead, defined by the tertiary structure of the protein. Furthermore, the expression system (bacteria, yeast, insect cells, mammalian cells), the expression condition used (4), the sensitivity of the recombmant antigen to host proteases (5), and the number of steps involved in the purification procedure may have relevant effects on the yield and on the purity of the recombinant antigen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kos A, Molijn A, Blauw B., and Schellekens H. (1991) Baculovnus-directed high level expression of the hepatitis delta antigen in Spodoptera frugiperda cells. J. Gen Virol. 72, 833–842.
Calogero R, Barblen U., Borla M, Osborne S., Poisson F, and Bonelh F. (1993) Purification of recombinant hepatitis delta antigen expressed in E coli cells FEBS Lett 318, 322–324.
Osborne S., Cecconato E., Grrva S., Garetto F., Calogero R., and Bonelli F (1993) Expression in E coli and purification of a chimeric p22-NS3 recombinant antigen of Hepatitis C virus (HCV). FEBS Lett 324, 253–257
Schein C H. and Noteborn M H M (1988) Formation of soluble recombinant proteins in Escherlchia coli is favored by lower growth temperature Bio/Technology 6, 291–294
Babbitt P. C, West B. L., Buechter D. D., Kuntz I. D., and Kenyon G. L (1990) Removal of a proteolytic activity associated with aggregates formed from expression of creatme kmase in E coli leads to improved recovery of active enzyme Bio/Technology 8, 945–949.
Cleland J. L, Builder S E, Swartz J R., Winkler M, Chang J Y, and Wang D I (1992) Polyethylene glycol enhanced protem refolding. Bio/Technology 10, 1013–1019
Calogero R, Cecconato E, Manam M, Suppo M, Barbten U, Bonelh F, Mtlanesi G., and Gallina A (1989) Expression of HIV-1 gag gene in E co1i as a diagnostic test, in Advances in Applied Biotechnology Series, vol 7 (Papas T S, ed.), Gulf Publishing, Houston, TX, pp 327–336.
Georgiou G. and Bowden G. A (1991) Inclusion body formation and the recovery of aggregated recombinant proteins, in Recombinant DNA Technology and Application (Ho C, Prokop A, and Bajpai R., eds), McGraw-Hill, New York, pp 333–351
Hartley D and Kane J F. (1988) Properties of inclusion bodies from recombinant E coli Biochem Soc Trans 16, 101,102.
Cregg J. M, Tschopp J. F, Stillman C, Siegel R, Akong M, Craig W S, Buckholz R G, Madden K R., Kellaris P A, Davis G R, Smiley B L, Cruze J, Torregrossa R, Velicelebt G, and Thill G P (1987) High-level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast, Pichia pastoris. Bio/Technology 5, 479–485
Fraser M. J. (1992) The baculovirus-infected insect cell as eukariotic gene expression system, in Current Topxs in Microbiology and Immunology (Muzyczka N, ed), Springer-Verlag, Berlin, pp. 131–172
Mitraki A. and King J (1989) Protein folding intermediates and inclusion body formation. Bio/Technology 7, 690–697
Bowden G A, Paredes A M, and Georgtou G. (1991) Structure and morphology of protein inclusion bodies in Escherichia coli Bio/Technology 9, 725–730
Haase-Pettingell C A and King J. (1988) Formation of aggregates from a thermolabile in vivo folding intermediate in P22 tailspike maturation J Biol. Chem 263, 4977–4983
Frankel S., Sohn R, and Leinwand L (1991) The use of sarkosyl in generating soluble protem after bacterial expression Proc Natl Acad Sci USA 88, 1192–1196.
Soutschek E., Hoflacher B., and Motz M. (1990) Purification of a recombinantly produced transmembrane protein (gp41) of HIV-1. J Chromat 521, 267–277.
Arakawa T. and Timasheff S. N. (1985) Theory of protein solubihty Methods Enzymol 114, 49–77.
Laemmh U. K (1970) Cleavage of structural proteins during the assembly of the head of bactertophage T4 Nature 227, 680–685
Towbin H, Staehelin T., and Gordon J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to introcellulose sheets. procedure and some apphcations Proc NatL Acad Sci USA 76, 4350–4354
Talbot P V, Knobler R. L., and Buchmeler M. (1984) Western blot analysts of viral antigens and antibodies application to murine hepatitis virus. J Immunol Meth 73, 177–188
Catt KJKX, Ntall H D, and Tregear G W. (1967) Solid phase radioimmunoassay. Nature 213, 825–827
Catt K and Tregear G W. (1967) Solid-phase radioimmunoassay in antibodycoated tubes Science 158, 1570–1573
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc.
About this protocol
Cite this protocol
Calogero, R.A., Aulicino, A. (1998). Purification of Recombinant Proteins Having High Isoelectric Points. In: Reischl, U. (eds) Molecular Diagnosis of Infectious Diseases. Methods in Molecular Medicine™, vol 13. Humana Press, Totowa, NJ. https://doi.org/10.1385/0-89603-485-2:345
Download citation
DOI: https://doi.org/10.1385/0-89603-485-2:345
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-485-3
Online ISBN: 978-1-59259-597-6
eBook Packages: Springer Protocols